Cell & Molecular Therapies at Royal Prince Alfred Hospital


Cell & Molecular Therapies (CMT) is committed to the development and provision of novel cellular therapy products for clinical use. CMT helps bridge the gap between discovery research and clinical implementation of cell and tissue based products, through efficient transfer of laboratory methods into clinically relevant manufacturing protocols. The service aims to provide improved treatment options.


Two conventional cleanrooms plus 2 laboratory suites that operate at negative pressure to accommodate gene therapy protocols.

Year of Establishment


Access and Pricing

Available on application - All inclusive campaign pricing available.

Previous Clients

Academic and biotechnology industry partners
The Children's Hospital of Philadelphia
Athersys and ReGenesys



Four separate clean room suites with both positive and negative pressure clean rooms

Provide cGMP services to academic and industry partners for development, manufacture, clinical evaluation and implementation of cell and gene modified therapies

Cell selection, expansion and gene modification

Dedicated Production and Quality staff available for contract GMP work or option for your staff to work with us under GMP-compliant Quality System

Central environmental and equipment monitoring system operating 24/7 

Cell and gene therapy product storage and supply

Quality control and support laboratory 

Process development services including clinical trial support where the cell product and manufacturing processes are taken from research scale through to clinically relevant scale and method